Evidence map›Paper›PMID 38927185›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Emergence of Rarely Reported Extensively Drug-Resistant

Jiefu Peng, Jingchao Feng, Hong Ji, Xiaoxiao Kong, Jie Hong, Liguo Zhu, Huimin Qian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Genomic analysis of multidrug-resistantFrontiers in microbiology · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiefu PengNHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.ORCID 0009-0002-2830-0913
Jingchao FengSchool of Public Health, Xiamen University, Xiamen 361102, China.ORCID 0009-0008-4684-5283
Hong JiNHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
Xiaoxiao KongNHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
Jie HongNHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.ORCID 0000-0002-6480-0029
Liguo ZhuNHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
Huimin QianNHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.

Funding

Jiangsu Preventive Medicine Association Ym2023040Ministry of Science and Technology of the People's Republic of China National Major S&T Projects(2018ZX10714-002)
6 · The paper itself

Abstract

backgroundIn recent years, global concern over increasing multidrug resistance (MDR) among various

methodsIn this retrospective study, we investigated the isolates of

results27

conclusionsThis research underscores the pressing need for closely monitoring the MDR/XDR

Indexed as

ICESalmonella Paratyphi BST2814XDR

Identifiers

PMID38927185
PMCPMC11201502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.